7-Aug-2026
Globe Newswire (Sat, 8-Aug 8:43 AM ET)
Are D, NEE, ACA Obtaining Fair Deals for their Shareholders?
PRNewswire (Thu, 6-Aug 10:31 PM ET)
PRNewswire (Thu, 6-Aug 4:33 PM ET)
Arcosa misses top-line and bottom-line estimates; suspends FY26 outlook
Seeking Alpha News (Thu, 6-Aug 1:34 AM ET)
Arcosa, Inc. Announces Second Quarter 2026 Results
Business Wire (Wed, 5-Aug 4:15 PM ET)
Here are the major earnings after the close Wednesday
Seeking Alpha News (Wed, 5-Aug 10:00 AM ET)
Are ACA, CRNX, LEG Obtaining Fair Deals for their Shareholders?
PRNewswire (Mon, 3-Aug 7:39 PM ET)
PRNewswire (Mon, 3-Aug 3:21 PM ET)
Are FBRX, ACA, BGMS Obtaining Fair Deals for their Shareholders?
PRNewswire (Mon, 27-Jul 7:38 PM ET)
PRNewswire (Mon, 27-Jul 2:44 PM ET)
Arcosa Inc is a manufacturer and producer of infrastructure-related products and solutions in the U.S. It operates in three segments: Construction Products, Engineered Structures, and Transportation Products. Maximum revenue is generated from the Construction Products segment, which produces aggregates, specialty materials, asphalt, and construction support gear. The Engineered Structures segment mainly manufactures and sells steel and concrete structures for infrastructure businesses, including utility structures for electricity transmission and distribution, structural wind towers, traffic and lighting structures, and telecommunication structures; and the Transportation Products segment builds inland barges, fiberglass covers, winches, marine hardware, and other industrial equipment.
Arcosa Common trades on the NYSE stock market under the symbol ACA.
As of August 7, 2026, ACA stock price declined to $144.84 with 443,923 million shares trading.
ACA has a beta of 0.66, meaning it tends to be less sensitive to market movements. ACA has a correlation of 0.08 to the broad based SPY ETF.
ACA has a market cap of $7.11 billion. This is considered a Mid Cap stock.
Last quarter Arcosa Common reported $659 million in Revenue and $6.77 earnings per share. This fell short of revenue expectation by $-28 million and exceeded earnings estimates by $5.59.
In the last 3 years, ACA traded as high as $146.92 and as low as $61.98.
The top ETF exchange traded funds that ACA belongs to (by Net Assets): IJR, VTI, IWM, VB, VBR.
ACA has outperformed the market in the last year with a return of +70.4%, while the SPY ETF gained +23.5%. In the last 3 month period, ACA beat the market returning +13.2%, while SPY returned +6.0%. However, in the most recent 2 weeks ACA has underperformed the stock market by returning -0.1%, while SPY returned +4.6%.
ACA support price is $144.47 and resistance is $145.31 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ACA shares will trade within this expected range on the day.